ALEXANDRIA, Va., June 19 -- United States Patent no. 12,329,741, issued on June 17, was assigned to XI'AN XINTONG PHARMACEUTICAL RESEARCH Co. LTD. (Shaanxi, China).
"HBV inhibitor and its use" was invented by Weibo Guo (Xi'an, China), Dengke Zhang (Xi'an, China), Weili Jin (Xi'an, China), Mingzhe Ji (Xi'an, China) and Yanxia Zhang (Shaanxi, China).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides anti-HBV compounds, pharmaceutically acceptable compounds or stereoisomers thereof, and preparation methods and uses for treating, eradicating or inhibiting HBV infection or for alleviating liver injury caused by HBV infection, and so on."
The patent was filed on Nov. 17, 2023, under Appl...